Related Experiment Video
Updated: Aug 4, 2025

Cardiac Magnetic Resonance for the Evaluation of Suspected Cardiac Thrombus: Conventional and Emerging Techniques
Published on: June 11, 2019
Factors influencing left ventricular thrombus resolution and its significance on clinical outcomes
Se-Eun Kim1, Chan Joo Lee1, Jaewon Oh1
1Division of Cardiology, Severance Cardiovascular Hospital, Yonsei University College of Medicine, Seoul, Republic of Korea.
Insights
Left ventricular thrombus (LVT) resolution is linked to better clinical outcomes in patients with reduced ejection fraction. Failure of left ventricular ejection fraction (LVEF) improvement hinders LVT resolution and increases recurrence risk.
Area of Science:
- Cardiology
- Internal Medicine
Background:
- Left ventricular thrombus (LVT) is a common complication in patients with impaired left ventricular systolic function.
- Established treatment strategies for LVT are lacking, necessitating research into factors influencing its resolution and clinical impact.
Purpose of the Study:
- To identify factors associated with LVT resolution.
- To determine the clinical significance of LVT resolution on patient outcomes.
- To investigate predictors of LVT recurrence after resolution.
Main Methods:
- Retrospective analysis of 212 patients with LVT and left ventricular ejection fraction (LVEF) < 50% from January 2010 to July 2021.
- LVT resolution monitored via serial echocardiography.
- Primary outcome: composite of all-cause death, stroke, transient ischemic attack, and arterial thromboembolism; LVT recurrence also evaluated.
Main Results:
- LVT resolution occurred in 84.4% of patients.
- Failure of LVEF improvement within 6 months significantly hindered LVT resolution (HR: 0.52).
- LVT resolution was independently associated with a lower risk of adverse clinical outcomes (HR: 0.45).
- LVEF improvement failure at LVT resolution predicted higher recurrence risk (HR: 3.10).
Conclusions:
- LVT resolution is a significant predictor of favorable clinical outcomes.
- Impaired LVEF improvement is a key factor impeding LVT resolution and promoting recurrence.
- Anticoagulation continuation post-resolution did not significantly impact recurrence or prognosis.
Aims:
A left ventricular thrombus (LVT) is not uncommon in patients with impaired LV systolic function. However, the treatment strategy for LVT has not yet been fully established. We aimed to identify the factors influencing LVT resolution and the significance of LVT resolution on clinical outcomes.
Methods:
We retrospectively investigated patients diagnosed with LVT with left ventricular ejection fraction (LVEF) < 50% on transthoracic echocardiography from January 2010 to July 2021 in a single tertiary centre. LVT resolution was monitored through serial follow-up transthoracic echocardiography. The primary clinical outcome was a composite of all-cause death, stroke, transient ischaemic attack, and arterial thromboembolic events. LVT recurrence was also evaluated in patients with LVT resolution.
Results:
There were 212 patients diagnosed with LVT (mean age, 60.5 ± 14.0 years; male, 82.5%). The mean LVEF was 33.1 ± 10.9%, and 71.7% of patients were diagnosed with ischaemic cardiomyopathy. Most patients were treated with vitamin K antagonists (86.7%), and 28 patients (13.2%) were treated with direct oral anticoagulants or low molecular weight heparin. LVT resolution was observed in 179 patients (84.4%). LVEF improvement failure within 6 months was a significant factor hindering LVT resolution (hazard ratio, HR: 0.52, 95% confidence interval, CI: 0.31-0.85, P = 0.010). During a median 4.0 years of follow-up (interquartile range, IQR: 1.9 to 7.3 years), 32 patients (15.1%) experienced primary outcomes (18 all-cause deaths, 15 strokes, and 3 arterial thromboembolisms) and 20 patients (11.2%) experienced LVT recurrence after LVT resolution. LVT resolution was independently associated with a lower risk for primary outcomes (HR: 0.45, 95% CI: 0.21-0.98, P = 0.045). In the patients with resolved LVT, discontinuation or duration of anticoagulation after resolution were not significant predictors for LVT recurrence, but LVEF improvement failure at LVT resolution was associated with a significantly higher risk of LVT recurrence (HR: 3.10, 95% CI: 1.23-7.78, P = 0.016).
Conclusions:
This study suggests that LVT resolution is an important predictor for favourable clinical outcomes. LVEF improvement failure interfered with LVT resolution and appeared to be a crucial factor for LVT recurrence. After LVT resolution, continuation of anticoagulation did not seem to impact LVT recurrence and the prognosis.
More Related Videos
14:35Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs
Published on: April 17, 2021
09:19In Vitro Microfluidic Disease Model to Study Whole Blood-Endothelial Interactions and Blood Clot Dynamics in Real-Time
Published on: May 24, 2020
Related Concept Videos
Venous Thrombosis I: Introduction
Venous Thrombosis III: Interprofessional Care
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Clot Retraction and Fibrinolysis
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies